- Price is above Fair Value, showing premium demand versus the model.
DEX
STO
Week ended 07 Aug 2026
Weekly Investor Report
DexTech Medical AB · Healthcare · Biotechnology
Latest close
10.10 SEK
-6.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -2.6% below the Trend Line and sits at 49.7% of its 52-week range. The latest completed week returned -6.0%, after a -1.9% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
34
out of 100
Latest Close
10.10 SEK
7 Aug 2026
1W Return
-6.0%
latest completed week
4W Return
-1.9%
short-term follow-through
12W Return
0.5%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 39.38% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.0%
Latest completed week; four-week move -1.9%.
Indicator stack
49/47
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.38%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.6% below the Trend Line and sits at 49.7% of its 52-week range. The latest completed week returned -6.0%, after a -1.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5012-week average 0.52
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.9% over four weeks, 0.5% over 12 weeks, and 26.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.26Latest activity-pressure read.
Pressure change24.5%Four-week change in activity pressure.
Leadership-4.68Latest relative-leadership reading.
RS change-328.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.9%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+5.8%Week of 12 Jun.
Worst week-6.0%Week of 7 Aug.
Latest week-6.0%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks1
Modest losses10
Sharp losses4
Recent vol3.7%13-week weekly-return volatility.
Base vol6.8%52-week weekly-return volatility.
Up/down split24/26Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank59 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank30 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis51/100Latest 12-week confirmation: trend 11/12, activity pressure 0/12, relative leadership 9/12.
Activity pressure 0.50; 2 reversal markers Next-Week ExpectancyNegative 39.38%Next-week expectancy is negative with a 39.38% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Medical Technology Stocks: Innovation Endures as Valuations Reset Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 10.10 SEK | -6.0% | 10.37 SEK | 6.39 SEK | -0.26 | -4.68 | 13.1K | Off |
| 31 Jul 2026 | 10.75 SEK | 2.9% | 10.31 SEK | 6.36 SEK | -0.24 | 3.49 | 7.0K | On |
| 24 Jul 2026 | 10.45 SEK | 1.0% | 10.26 SEK | 6.32 SEK | -0.42 | 2.25 | 21.8K | On |
| 17 Jul 2026 | 10.35 SEK | 0.5% | 10.21 SEK | 6.28 SEK | -0.48 | 3.26 | 6.8K | On |
| 10 Jul 2026 | 10.30 SEK | 1.0% | 10.17 SEK | 6.24 SEK | -0.34 | 2.05 | 22.9K | On |
| 3 Jul 2026 | 10.20 SEK | -3.8% | 10.16 SEK | 6.21 SEK | -0.29 | -0.89 | 2.7K | On |
| 26 Jun 2026 | 10.60 SEK | 2.9% | 10.11 SEK | 6.17 SEK | -0.25 | 6.15 | 3.2K | On |
| 19 Jun 2026 | 10.30 SEK | -5.5% | 10.01 SEK | 6.13 SEK | -0.37 | 2.65 | 78.1K | On |
| 12 Jun 2026 | 10.90 SEK | 5.8% | 9.90 SEK | 6.10 SEK | -0.65 | 10.88 | 3.6K | On |
| 5 Jun 2026 | 10.30 SEK | 5.5% | 9.78 SEK | 6.06 SEK | -0.85 | 4.96 | 31.8K | On |
| 29 May 2026 | 9.76 SEK | -2.4% | 9.67 SEK | 6.02 SEK | -0.85 | -1.35 | 35.9K | On |
| 22 May 2026 | 10.00 SEK | -0.5% | 9.57 SEK | 5.99 SEK | -0.77 | 1.45 | 16.8K | On |
| 15 May 2026 | 10.05 SEK | -2.9% | 9.47 SEK | 5.96 SEK | -0.63 | 6.15 | 22.7K | On |
| 8 May 2026 | 10.35 SEK | 3.0% | 9.38 SEK | 5.92 SEK | -0.52 | 9.08 | 49.5K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.